Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation
Satish Shanbhag1,2, Mitchell R Smith1, Robert VB Emmons21Department of Medical Oncology, Fox Chase Cancer Center, 2Division of Bone Marrow Transplantation, Temple University, Philadelphia, PA, USAAbstract: Mantle cell lymphoma (MCL) is a type of non-Hodgkins lymphoma (NHL) associated with poor progr...
Enregistré dans:
Auteurs principaux: | Satish Shanbhag, Mitchell R Smith, Robert VB Emmons |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2010
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d68f3bca3b8a4460ae9101b261536de9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Some aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversy
par: Blau O, et autres
Publié: (2014) -
Hematopoietic stem cell transplantation for the management of follicular lymphoma
par: Chitra Hosing
Publié: (2010) -
Hematopoietic stem cell transplantation
par: Eleftheria Hatzimichael, et autres
Publié: (2010) -
Treatment of systemic sclerosis: potential role for stem cell transplantation
par: Wen Xiong, et autres
Publié: (2009) -
Cat amniotic membrane multipotent cells are nontumorigenic and are safe for use in cell transplantation
par: Vidane AS, et autres
Publié: (2014)